Republic Technologies Doubles ETH Holdings Amid 23% Appreciation in Total Value

Republic Technologies Doubles ETH Holdings Amid 23% Appreciation in Total Value

Republic Technologies Inc. (CSE: DOCT,OTC:DOCKF) (FSE: 7FM0) (WKN: A41AYF) (OTCQB: DOCKF) (the " Company " or " Republic ") is pleased to announce a significant expansion of its ETH holdings and continued progress in strengthening its infrastructure foundation, further enhancing its capacity of generating attestations that safeguard data integrity for universal applications.

Republic has purchased an additional 742.40 ETH , increasing total holdings to 1,570.60 ETH at a blended cost of approximately US$2,700 per ETH, for a total carrying value of roughly US$4.27 million . Based on the market price as of December 10, 2025, approximately US$3,300 per ETH, the holdings are worth around US$5.27 million , representing an estimated 23% appreciation .

Republic holds ETH as an operational asset and deploys it into validator infrastructure to secure the Ethereum network and generate the attestations that drive its business. This model positions the Company at the core of Ethereum's rapidly developing ecosystem.

In parallel with expanding its infrastructure capacity, Republic employs sophisticated purchasing strategies, collectively referred to as "Synthetic Mining" , to acquire ETH at lower effective prices, generate additional revenue, and grow the balance sheet in ETH terms without issuing new equity. Over the past quarter, the Company allocated a portion of its balance sheet to Synthetic Mining strategies, which have generated average annualized returns in the range of 80% to 100% .

Following the Company's OTCQB listing and the completion of its first US$10 million drawdown under the previously announced US$100 million secured convertible note facility , this non-dilutive balance sheet growth further enhances Republic's capacity to scale validator operations and increase attestation output. These advancements move the Company closer to its mission of delivering trusted solutions that safeguard data integrity and benefiting the general public with advanced Ethereum technology .

"As Ethereum continues to gain adoption, Republic is strategically positioned to scale with the ecosystem's growth," said Daniel Liu, CEO of Republic Technologies. "Accelerating validator infrastructure deployment, expanding attestation capacity and expanding our ETH holdings remain core pillars to achieve our long-term strategy."

About Republic Technologies Inc.

Republic Technologies is a publicly traded technology company integrating Ethereum infrastructure into the global economy. Backed by an ETH-denominated treasury, we operate validator and attestation networks to safeguard data integrity for universal applications.

Forward-Looking Statements

This news release contains statements that constitute forward-looking information or forward-looking statements within the meaning of applicable securities laws. Such statements include, but are not limited to, expectations regarding the expansion of ETH holdings, deployment and scaling of validator and attestation infrastructure, anticipated returns from Synthetic Mining strategies, the Company's ability to strengthen its financial position without issuing new equity, benefits from its OTCQB listing and convertible note facility, and its long-term mission to enhance data integrity and adoption of Ethereum technology. Forward-looking statements are based on assumptions that include continued growth and adoption of Ethereum and related technologies, stability and liquidity in digital asset markets, the Company's ability to execute infrastructure deployment plans on schedule and within budget, a regulatory environment that remains supportive of blockchain-based operations, and ongoing access to financing under existing facilities under favorable market conditions. These statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied. Such risks include volatility in ETH and other digital asset prices, changes in blockchain protocols or validator economics, operational challenges in deploying and maintaining validator infrastructure, regulatory changes or restrictions affecting digital assets or blockchain operations, counterparty risk in Synthetic Mining strategies, market and liquidity risks, and broader economic and geopolitical factors. Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking information except as required by applicable law.

Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.

On behalf of the Board of Directors
Daniel Liu,
Chief Executive Officer
Tel: (778) 200-4124
Email: info@republictech.io
https://republictech.io/

News Provided by Business Wire via QuoteMedia

DOCT:CNX
The Conversation (0)
beyond medical

Beyond Medical Technologies

Keeping Canadians Healthy and Safe

Keeping Canadians Healthy and Safe Keep Reading...
Scientists working in a modern medical research laboratory.

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at... Keep Reading...
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the... Keep Reading...
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries CommenceDownload the PDF here. Keep Reading...
Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities. The groundbreaking developments in antifungal treatments specifically targeting women's health issues... Keep Reading...
Zero Candida Technologies (TSXV:ZCT)

Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025

Zero Candida Technologies, Inc. (TSXV: ZCT), (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing women's health, announces plans to complete preclinical studies for FDA submission by Q3 2025. In accordance with FDA requirements, the company... Keep Reading...

Interactive Chart

Latest Press Releases

Related News